Back to today’s briefing

Story perspectives

Study Uncovers HSV-1's Genome Manipulation, Paving Antiviral Advances

6/24/2025

48 9

Summary

Story summary

A groundbreaking study from Barcelona's Center for Genomic Regulation reveals how the herpes simplex virus-1 (HSV-1) cleverly alters the 3D structure of the human genome to boost its replication. By inhibiting the enzyme topoisomerase I, researchers successfully disrupted this manipulation, paving the way for innovative antiviral treatments that could benefit nearly four billion affected individuals worldwide.

1 of 1

Story summary

A groundbreaking study from Barcelona's Center for Genomic Regulation reveals how the herpes simplex virus-1 (HSV-1) cleverly alters the 3D structure of the human genome to boost its replication. By inhibiting the enzyme topoisomerase I, researchers successfully disrupted this manipulation, paving the way for innovative antiviral treatments that could benefit nearly four billion affected individuals worldwide.